SCHEMBL6570119

SCHEMBL6570119

CC1CSCC(C(=O)O)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 3/20 0.42
CYP2D6 P10635 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42
THRB P10828 1/20 0.42
PMP22 Q01453 1/20 0.42
ALDH1A1 P00352 8/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 5/20 0.39
KDM4E B2RXH2 5/20 0.39
S1PR3 Q99500 2/20 0.39
HSD17B10 Q99714 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9777782 1.00 BLM (0.42) BLMCYP2D6LMNAMEN1KMT2A
SCHEMBL29373309 0.84 BLM (0.60) BLMCYP2D6LMNAMEN1KMT2A
SCHEMBL8377074 0.78 KMT2A (0.40) KMT2ATSHRKDM4EHSD17B10HTT
SCHEMBL9035835 0.78 KMT2A (0.40) KMT2ATSHRKDM4EHSD17B10HTT
SCHEMBL9035842 0.78 KMT2A (0.40) KMT2ATSHRKDM4EHSD17B10HTT
SCHEMBL5287178 0.74
SCHEMBL28393659 0.74
SCHEMBL31384988 0.74
SCHEMBL27563566 0.74 BLM (0.38) BLMCYP2D6LMNAMEN1KMT2A
SCHEMBL4576765 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304034-B1 Plant protection and strengthening agents based on onions SE MA GES FUER INNOVATIONEN MB (DE) 2004-08-11 EP claimed
EP-1304034-A1 Plant protection and strengthening agents based on onions se ma Gesellschaft für Innovationen mbH (DE) 2003-04-23 EP claimed
US-20260124167-A1 SIRTUIN ACTIVATOR OR EXPRESSION ENHANCER, NAD+ INCREASING AGENT, AND SENESCENT CELL INHIBITOR WAKUNAGA PHARMA CO LTD (JP) 2026-05-07 US disclosed
EP-4603089-A1 SIRTUIN ACTIVATOR OR EXPRESSION ENHANCER, NAD+ INCREASING AGENT, AND SENESCENT CELL INHIBITOR Wakunaga Pharmaceutical Co., Ltd. (JP) 2025-08-20 EP disclosed
CN-120018843-A Histone deacetylase activation or expression enhancers, NAD+Potentiators and senescent cell inhibitors 涌永制药株式会社 2025-05-16 CN disclosed
WO-2024080323-A1 SIRTUIN ACTIVATOR OR EXPRESSION ENHANCER, NAD+ INCREASING AGENT, AND SENESCENT CELL INHIBITOR 湧永製薬株式会社 2024-04-18 WO disclosed
EP-1304034-B1 Plant protection and strengthening agents based on onions SE MA GES FUER INNOVATIONEN MB (DE) 2004-08-11 EP disclosed
EP-1304034-A1 Plant protection and strengthening agents based on onions se ma Gesellschaft für Innovationen mbH (DE) 2003-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124167-A1 SIRTUIN ACTIVATOR OR EXPRESSION ENHANCER, NAD+ INCREASING AGENT, AND SENESCENT CELL INHIBITOR SIRT1, SIRT3, SIRT2 BLM 4305/4885CYP2D6 4706/4885LMNA 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.